309 related articles for article (PubMed ID: 24762056)
1. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
2. Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability.
Lange S; Gögel S; Leung KY; Vernay B; Nicholas AP; Causey CP; Thompson PR; Greene ND; Ferretti P
Dev Biol; 2011 Jul; 355(2):205-14. PubMed ID: 21539830
[TBL] [Abstract][Full Text] [Related]
3. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
4. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic-Ischemic Encephalopathy.
Lange S
Front Neurol; 2016; 7():22. PubMed ID: 26941709
[TBL] [Abstract][Full Text] [Related]
6. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
9. Atomoxetine, a selective norepinephrine reuptake inhibitor, improves short-term histological outcomes after hypoxic-ischemic brain injury in the neonatal male rat.
Toshimitsu M; Kamei Y; Ichinose M; Seyama T; Imada S; Iriyama T; Fujii T
Int J Dev Neurosci; 2018 Nov; 70():34-45. PubMed ID: 29608930
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of calpain inhibitor-3 on hypoxic-ischemic brain damage of neonatal rats].
Chen LN; Yan B; Chen DP; Yao YJ
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):13-7. PubMed ID: 18353231
[TBL] [Abstract][Full Text] [Related]
11. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
[TBL] [Abstract][Full Text] [Related]
12. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
13. A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.
Kholia S; Jorfi S; Thompson PR; Causey CP; Nicholas AP; Inal JM; Lange S
J Extracell Vesicles; 2015; 4():26192. PubMed ID: 26095379
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated kinase 2 has duality in function between neuronal and astrocyte expression following neonatal hypoxic-ischaemic cerebral injury.
Thei L; Rocha-Ferreira E; Peebles D; Raivich G; Hristova M
J Physiol; 2018 Dec; 596(23):6043-6062. PubMed ID: 29873394
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.
Fleiss B; Nilsson MK; Blomgren K; Mallard C
J Neuroinflammation; 2012 Apr; 9():70. PubMed ID: 22512781
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.
Arteaga Cabeza O; Zhang Z; Smith Khoury E; Sheldon RA; Sharma A; Zhang F; Slusher BS; Kannan RM; Kannan S; Ferriero DM
Neurobiol Dis; 2021 Jan; 148():105201. PubMed ID: 33271328
[TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
19. Monocytes promote acute neuroinflammation and become pathological microglia in neonatal hypoxic-ischemic brain injury.
Chen HR; Chen CW; Kuo YM; Chen B; Kuan IS; Huang H; Lee J; Anthony N; Kuan CY; Sun YY
Theranostics; 2022; 12(2):512-529. PubMed ID: 34976198
[No Abstract] [Full Text] [Related]
20. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
Wang S; Wang Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
